Applicability of induced sputum for molecular dosimetry of exposure to inhalatory carcinogens: 32P-postlabeling of lipophilic DNA adducts in smokers and nonsmokers

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 4, 2000, Pages 367-372

  Nia, Ahmad Besarati ^a   Maas, Lou M ^a   Van Breda, Simone G J ^a   Curfs, Daniëlle M J ^a   Kleinjans, Jos C S ^a   Wouters, Emiel F M ^b   Van Schooten, Frederik J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; PHOSPHORUS 32;

ADULT; AGED; ARTICLE; CELL VIABILITY; CIGARETTE SMOKING; CLINICAL ARTICLE; DNA ADDUCT; DNA CONTENT; DOSIMETRY; EXPOSURE; FEMALE; HUMAN; LEUKOCYTE DIFFERENTIAL COUNT; LIPOPHILICITY; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; PRIORITY JOURNAL; SAMPLING; SPUTUM ANALYSIS;

ADULT; CARCINOGENS; DNA ADDUCTS; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; INHALATION EXPOSURE; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; PHOSPHORUS RADIOISOTOPES; SENSITIVITY AND SPECIFICITY; SMOKING; SPUTUM; TOBACCO SMOKE POLLUTION;

EID: 0034062877     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Pisani, P., Parkin, D. M., and Ferlay, J. Estimates of the worldwide mortality for eighteen major cancers in 1985: implications for prevention and projections of future burden. Int. J. Cancer, 55: 891-903, 1993.
2. Boyle, P., and Maisonneuve, P. Lung cancer and tobacco smoking. Lung Cancer, 12: 167-181, 1995.
3. IARC. Tobacco smoking. In: Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 38. Lyon, France: IARC, 1986.
4. Loeb, L. A., Ernster, V. L., Warner, K. E., Abbots, J., and Laszlo, J. Smoking and lung cancer: an overview. Cancer Res., 44: 5940-5958, 1984.
5. Hoffmann, D., and Hecht, S. S. Nicotine-derived N-nitrosamines, and tobacco-related cancer: current status and future directions. Cancer Res., 45: 935-944, 1985.
6. Surgeon General. The health consequences of involuntary smoking. In: A Report of Surgeon General. Rockville, Maryland: Office of Smoking and Health, 1986.
7. Spivack, S. D., Fasco, M. J., Walker, V. E., and Kaminsky, L. S. The molecular epidemiology of lung cancer. Crit. Rev. Toxicol., 27: 319-365, 1997.
8. Patriakanos, C., and Hoffmann, D. Chemical studies on tobacco smoke. J. Anal. Toxicol., 3: 184-197, 1979.
9. Hoffmann, D., and Hoffmann, I. The changing cigarette, 1950-1995. J. Toxicol. Environ. Health, 50: 307-364, 1997.
10. Miller, E. C., and Miller, J. A. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer (Phila.), 47: 2327-2345, 1981.
11. Hemminki, K. DNA adducts, mutations and cancer. Carcinogenesis (Lond.), 14: 2007-2012, 1993.
12. 32P-postlabeling assay. Carcinogenesis (Lond.), 13: 1053-1074, 1992.
13. Poirier, M. C., and Weston, A. Human DNA adduct measurements: state of the art. Environ. Health Perspect., 104: 883-893, 1996.
14. Phillips, D. H., Hewer, A., Martin, C. N., Garner, R. C., and King, M. M. Correlation of DNA adduct levels in human lung with cigarette smoking. Nature (Lond.), 336: 790-792, 1988.
15. Perera, F., Mayer, J., Jaretzki, A., Hearne, S., Brenner, D., Young, T. L., Fischman, H. K., Grimes, M., Grantham, S., Tang, M. X., Tsai, W. Y., and Santella, R. M. Comparison of DNA adducts and sister chromatid exchange in lung cancer cases and controls. Cancer Res., 49: 4446-4451, 1989.
16. Cuzick, J., Routledge, M. N., Jenkins, D., and Colin Garner, R. DNA adducts in different tissues of smokers and non-smokers. Int. J. Cancer, 45: 673-678, 1990.
17. Van Schooten, F. J., Hillebrand, M. J. X., Van Leeuwen, F. E., Lutgerink, J. T., Van Zandwijk, N., Jansen, H. M., and Kriek, E. Polycyclic aromatic hydrocarbon-DNA adducts in lung tissue from lung cancer patients. Carcinogenesis (Lond.), 11: 1677-1681, 1990.
18. 32P-postlabeling and aryl hydrocarbon hydroxylase activity in lung parenchyma of smokers and ex-smokers. Carcinogenesis (Lond.), 12: 1301-1305, 1991.
19. Nowak, D., Meyer, A., Schmidt Preuss, U., Gatzemeier, U., Magnussen, H., and Rüdiger, H. W. Formation of benzo[a]pyrene-DNA adducts in blood monocytes from lung cancer patients with a familial history of lung cancer. J. Cancer Res. Clin. Oncol., 118: 67-71, 1992.
20. Alexandrov, K., Rojas, M., Geneste, O., Castegnaro, M., Camus, A. M., Petruzzelli, S., Ciuntini, C., and Bartsch, H. An improved fluorometric assay for dosimetry of benzo[a]pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydroxylase activity. Cancer Res., 52: 6248-6253, 1992.
21. Dennis, N., Meyer, A., Schmidt Preuss, U., Gatzemeier, U., Magnussen, H., and Rüdiger, H. W. Formation of benzo[a]pyrene-DNA adducts in blood monocytes from lung cancer patients with a familial history of lung cancer. J. Cancer Res. Clin. Oncol., 118: 67-71, 1992.
22. Weston, A., Bowman, E. D., Schields, P. G., Trivers, G., E., Poirier, M., C., Santella, R. M., and Manchester, D. K. Detection of polycyclic aromatic hydrocarbon-DNA adducts in human lung. Environ. Health Perspect., 99: 257-259, 1993.
23. 32P-postlabeling analysis of PAH-DNA adducts in human lung and the relationship to TP53 mutations. Mutat. Res., 368: 275-282, 1996.
24. Ryberg, D., Skaug, V., Hewer, A., Phillips, D. H., Harries, L. W., Ronald Wolf, C., Øgreid, D., Ulvik, A., Vu, Ph., and Haugen, A. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis (Lond.), 18: 1285-1289, 1997.
25. Tang, D. L., Rundle, A., Warburton, D., Santella, R. M., Tsai, W. Y., Chiamprasert, S., Hsu, Y. Z., and Perera, F. P. Association between both genetic and environmental biomarkers and lung cancer: evidence of a greater risk of lung cancer in women smokers. Carcinogenesis (Lond.), 19: 1949-1953, 1998.
26. Phillips, D. H., Schoket, B., Hewer, A., Bailey, E., Kostic, S., and Vincze, I. Influence of cigarette smoking on the levels of DNA adducts in human bronchial epithelium and white blood cells. Int. J. Cancer, 46: 569-575, 1990.
27. 32P-postlabelling assay. Carcinogenesis (Lond.), 12: 503-508, 1990.
28. Van Schooten, F. J., Hillebrand, M. J. X., Van Leeuwen, F. E., Van Zandwijk, N., Jansen, H. M., Den Engelse, L., and Kriek, E. Polycyclic aromatic hydrocarbon-DNA adducts in white blood cells from lung cancer patients: no correlation with adduct levels in lung. Carcinogenesis (Lond.), 13: 987-993, 1992.
29. Wiencke, J. K., Kelsey, K. T., Varkonyi, A., Semey, K., Wain, J. C., Mark, E., and Christini, D. C. Correlation of DNA adducts in blood mononuclear cells with tobacco carcinogen-induced damage in human lung. Cancer Res., 55: 4910-4914, 1995.
30. Godschalk, R. W. L., Maas, L. M., Van Zandwijk, N., Van't veer, L. J., Breeedijk, A., Borm, P. J. A., Verhaert, J., Kleinjans, J. C. S., and Van Schooten, F. J. Differences in aromatic-DNA adduct levels between alveolar macrophages and subpopulations of white blood cells from smokers. Carcinogenesis (Lond.), 19: 819-825, 1998.
31. Sakula, A. Charcot-leyden crystals and cruschmann spirals in asthmatic sputum. Thorax, 41: 503-507, 1986.
32. Shata, A. M. A., Coulter, J. B. S., Parry, C. M., Ching'ani, G., Broadhead, R. L., and Hart, C. A. Sputum induction for the diagnosis of tuberculosis. Arch. Dis. Child., 74: 535-537, 1996.
33. Keatings, V. M., Collins, P. D., Scott, D. M., and Barnes, P. J. Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am. J. Respir. Crit. Care Med., 153: 530-534, 1996.
34. Pavord, I. D., Pizzichini, M. M. M., Pizzichini, E., and Hargreave, F. E. The use of induced sputum to investigate airway inflammation. Thorax, 52: 498-501, 1997.
35. Mathis, A., Rainer, W., Kuster, H., and Speich, R. Simplified sample processing combined with sensitive one-tube nested PCR assay for detection of Pneumocystis carinii in respiratory specimens. J. Clin. Microbiol., 35: 1691-1695, 1997.
36. 32P-postlabeling of aromatic DNA adducts in white blood cells and alveolar macrophages of smokers: saturation at high exposures. Mutat. Res., 378: 65-75, 1997.
37. 32P-postlabeling analysis of aromatic carcinogen: DNA adducts. Cancer Res., 45: 5656-5662, 1985.
38. Gershman, N. H., Wong, H. H., Liu, J. T., Mahlmeister, M. J., and Fahy, J. V. Comparison of two methods of collecting induced sputum in asthmatic subjects. Eur. Respir. J., 9: 2448-2453, 1996.
39. Pizzichini, E., Pizzichini, M. M. M., Efthimiadis, A., Hargreave, F. E., and Dolovich, J. Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination. Eur. Respir. J., 9: 1174-1180, 1996.
40. Popov, T. A., Pizzichini, M. M. M., Pizzichini, E., Kolendowicz, R., Punthakee, Z., Dolovich, J., and Hargreave, F. E. Some technical factors influencing the induction of sputum for cell analysis. Eur. Respir. J., 8: 559-565, 1995.
41. Fahy, J. V., Wong, H., Liu, J., and Boushey, H. A. Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects. Am. Respir. Crit. Care Med., 152: 53-58, 1995.
42. 2 exposure on induced sputum in normal, asthmatic and COPD subjects. Eur. Respir. J., 9: 1852-1857, 1996.
43. Kidney, J. C., Wong, A. G., Efthimiadis, A., Morris, M. M., Sears, M. R., Dolovich, J., and Hargreave, F. Elevated B cells in sputum of asthmatics: close correlation with eosinophils. Am. J. Respir. Crit. Care Med., 153: 540-544, 1996.
44. Keatings, V. M., and Barnes, P. J. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am. J. Respir. Crit. Care Med., 155; 449-453, 1997.
45. Chalmers, G. W., Thomson, L., Macleod, K. J., Dagg, K. D., McGinn, B. J., McSharry, Ch., Patel, K. R., and Thomson, N. C. Endothelin-1 levels in induced sputum samples from asthmatic and normal subjects. Thorax, 52: 625-627, 1997.
46. Lensmar, C., Elmberger, G., Skold, M., and Eklund, A. Smoking alters the phenotype of macrophages in induced sputum. Respir. Med., 92: 415-420, 1998.
47. Smith, C., and Wood, E. Immunological defense. In: C. Smith and E. Wood (eds.), Cell Biology, pp. 430. London: Chapman & Hall, 1996.
48. Øvrebø, S., Haugen, A., Phillips, D. H., and Hewer, A. Detection of polycyclic aromatic hydrocarbon-DNA adducts in white blood cells from coke oven workers: correlation with job categories. Cancer Res., 52: 1510-1514, 1992.
49. Simons, A. M., Van Herckenrode, C. M., Rodriguez, J. A., Maitland, N., Anderson, M., Phillips, D. H., and Coleman, D. V. Demonstration of smoking-related DNA damage in cervical epithelium and correlation with human papillomavirus type 16, using exfoliated cervical cells. Br. J. Cancer, 71: 246-249, 1995.
50. 32P-adduct assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures. Carcinogenesis (Lond.), 9: 29-36, 1988.
51. 32P-postlabeling assay after either 1-butanol extraction or the nuclease P1 treatment. Cancer Lett., 45: 7-12, 1989.
52. Izzotti, A., Rossi, G. A., Bagnasco, M., and De Flora, S. Benzo[a]pyrene diolepoxide-DNA adducts in alveolar macrophages of smokers. Carcinogenesis (Lond.), 12: 1281-1285, 1991.
53. De Flora, S., Izzotti, A., D'Agostini, F., Rossi, G. A., and Balansky, R. M. Pulmonary alveolar macrophages in molecular epidemiology and chemoprevention of cancer. Environ. Health Perspect, 99: 249-252, 1993.
54. 32P-postlabeled DNA adducts. J. Chromatogr. B. Biomed. App., 677: 265-273, 1996.